The Cologuard Plus test is being offered as an in-network service to eligible Humana Medicare Advantage members.

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced an expanded ...

"Exact Sciences团队很自豪能够通过与Humana的合作扩大Cologuard Plus的使用范围，使更多人能够在家中舒适地使用这种革命性的非侵入性结直肠癌筛查测试，"Exact Sciences筛查部门执行副总裁兼总经理Jake Orville表示。

Louisville, Ky.-based Humana contracted with Madison, Wis.-based Exact Sciences Corp. to cover Cologuard — a colon cancer test — as an in-network service for its members. Effective Jan. 1 ...

Cologuard Plus met all BLUE-C study endpoints, demonstrating 94% sensitivity for CRC at 91% specificity including non-advanced findings, and 93% specificity including no findings.

Madison, Wis.-based Exact Sciences Corp. agreed to a contract with Louisville, Ky.-based Humana to cover its Cologuard colon cancer screening test as an in-network service.

Exact Sciences said the original Cologuard test will still be available during a transition period, while the company works to gather coverage from commercial payers. On the company’s last ...

Ten years after first collecting an FDA approval, it’s time for version number two. Exact Sciences has received an agency green light for Cologuard Plus, the next generation of its mainstay, at ...

Colorectal Cancer Awareness Month is observed every year during March and aims to promote screening and early detection, raise awareness, and offer support to those battling the disease. Since March ...

Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, today announced the U.S. Food and Drug Administration approved the Cologuard Plus™ test, the company’ s next ...

Cologuard Plus is a more sensitive version of the original Cologuard that was first approved in 2014. The test is for people 45 and older who are at average risk of colorectal cancer, meaning ...

And although Exact’s colorectal fecal-based screening test (Cologuard) has been experiencing strong growth, at $1.1 billion of sales in 2021, compared with under $500 million three years ago ...